Daily Archives: June 20, 2016

Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Parents Worry about the Safety of Talcum Powder Use for Infants and Children

In light of the recent St. Louis trial verdict linking the use of Johnson’s Baby Powder to the development of ovarian cancer, parents are questioning the safety of talcum powder for use on babies and small children. Kelly Hartzell, owner … Continue reading

Posted in Health Concerns |

Whole Foods Receives FDA Warning Letter Citing Serious Violations

A letter dated June 8, 2016 from the U.S. Food and Drug Administration (FDA) was sent to Whole Foods Co-CEOs John Mackey and Walter Robb after a February inspection revealed some alarming violations. The Whole Foods food preparation facility in … Continue reading

Posted in Food Products, Health Concerns, Legal News, Listeria |

Stronger Warnings Added to Invokana Diabetes Medication

The U.S. Food and Drug Administration (FDA) has recently issued more severe warnings about the popular diabetes medication Invokana (canagliflozin) and an increased risk of amputation and other serious side effects including severe urinary tract infection, kidney failure, and heart … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Within One Month, FDA Issues Two Safety Alerts for Invokana

In the last month, the Food and Drug Administration (FDA) has issued two separate safety warnings involving the type 2 diabetes drug Invokana (canagliflozin). On May 18, 2016, and FDA alert reported that patients in a clinical trial studying Janssen … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Is It Safe to Use Spray Self-Tanners?

With increased awareness about the risks of UV exposure, more consumers are starting to use products that produce a tan without the damaging effects of the sun. But are these products safe? Time magazine reports that, according to dermatology experts, … Continue reading

Posted in Legal News |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.